Metformin Transport Rates Between Plasma and Red Blood Cells in Humans
Authors:
Open Access
- 26 July 2021
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 61 (1) , 133-142
Abstract
Background Metformin has been used for the treatment of type 2 diabetes for over 60 years; however, its mechanism of pharmacological action is not fully clear. Different hypotheses exist regarding metformin distribution and redistribution mechanisms between plasma and erythrocytes/red blood cells (RBCs). Objective We aimed to test the hypothesis that the metformin distribution between plasma and RBC occurs via concentration difference-driven passive transport and estimated transport rate coefficient values based on metformin concentration time series in plasma and RBCs from in vivo studies. Methods An ordinary differential equation (ODE) system with two compartments was used to describe diffusion-based passive transport between plasma and RBCs. Metformin concentration time series in plasma and RBCs of 35 individuals were used for metformin transport parametrization. Plasma concentration has been approximated by biexponential decline. Results A single passive transport coefficient, k = 0.044 ± 0.014 (h–1), can be applied, describing the uptake and release transport rate versus the linear equation v = k × (Mpl − MRBC), where Mpl is the metformin concentration in plasma and MRBC is the metformin concentration in RBCs. Conclusions Our research suggests that passive transport can explain metformin distribution dynamics between plasma and RBCs because transport speed is proportional to the metformin concentration difference and independent of the transport direction. Concentration difference-driven passive transport can explain the mechanism of faster metformin distribution to RBCs the first few hours after administration, and faster release and domination of the redistribution transport rate after metformin concentration in plasma becomes smaller than in RBCs.Keywords
Funding Information
- Latvijas Zinātnes Padome (LZP‐2018/2‐0088, LZP‐2018/2‐0088, LZP‐2018/2‐0088, LZP‐2018/2‐0088, LZP‐2018/2‐0088)
- H2020 Excellent Science (857572)
This publication has 36 references indexed in Scilit:
- ConvAn: A convergence analyzing tool for optimization of biochemical networksBioSystems, 2012
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 2011
- Pharmacokinetic Compartmental Modeling2007
- COPASI—a COmplex PAthway SImulatorBioinformatics, 2006
- Physiologically Based Pharmacokinetic Modeling 1: Predicting the Tissue Distribution of Moderate-to-Strong BasesJournal of Pharmaceutical Sciences, 2005
- Kinetics of plasma and erythrocyte metformin after acute administration in healthy subjectsDiabetes & Metabolism, 2003
- THE FATE OF XENOBIOTICS IN LIVING ORGANISMS2003
- The Antihyperglycaemic Effect of MetforminDrugs, 1999
- Clinical Pharmacokinetics of MetforminClinical Pharmacokinetics, 1996
- Accumulation of metformin by tissues of the normal and diabetic mouseXenobiotica, 1994